ACCESSIBILITY

24/7

Headlines

13:00

Bites raises $40 million Series A to bring AI training to frontline workers

12:40

Technion receives $25 million donation to study why some people age better than others

12:30

"There's no chance we beat San Francisco on a non-contrarian move"

11:36

Stealth Israeli cyber startup valued at over $1.5 billion recruits former 8200 chief

Buzz

Most popular

Daily

Weekly

Intel’s $2.3 billion Classiq deal follows years of personal investment by Lip-Bu Tan

Nikesh Arora's pay falls 19.5% to $80 million as Palo Alto Networks board lowers cap on stock awards

Intel to acquire Israeli quantum startup Classiq for $2.3 billion

Microsoft offers buyouts to 60,000 workers but says layoffs remain an option

Israeli startup raises $5 million to rethink one of surgery's most invasive procedures

More news

Nasdaq

20 stories about Nasdaq

Sustained Drug Release Company UroGen Aiming to Raise $150 Million on Nasdaq

24.01.19|Lilach Baumer

Goldman Sachs & Co. LLC, JP Morgan, and Jefferies are the joint bookrunners for the offering

Medical Device Company Brainsway Wants to Raise $30 Million on Nasdaq

16.01.19|Lilach Baumer

Jerusalem-headquartered Brainsway develops headsets that use magnetic stimulation to treat brain disorders

Security Contractor Magal Awarded $2.5 Million Spanish Port Contract

14.01.19|Shir Reiter and Adi Pick

Nasdaq-listed Magal has signed a contract to supply security technology and services to the port of Huelva, Spain

Thoma Bravo Completes Acquisition of Imperva

14.01.19|Lilach Baumer

The technology investment firm announced an agreement to buy Nasdaq-listed information security company Imperva for $2.1 billion in October 2018

Cancer Treatment Company Anchiano Therapeutics Wants to List on Nasdaq

09.01.19|Lilach Baumer

The company formerly known as BioCanCell submitted a prospectus to the SEC on Monday, with Oppenheimer & Co. as the sole underwriter

President of Nice Israel Miki Migdal Leaves Company

02.01.19|Meir Orbach

Migdal led the software company’s enterprise group, which has recently moved the bulk of its activity to the U.S.

KLA-Tencor's $3.4 Billion Orbotech Acquisition Stuck in China

25.12.18|Lilach Baumer

After getting the nod from regulators in the Korea, Israel, the U.S., Taiwan, and Japan, the companies announced Monday the deal is still pending approval in China

As Self-Imposed Acquisition Deadline Grows Near, Orbotech’s Stock Continues Downturn

23.12.18|Lilach Baumer

Consumer electronics company Orbotech’s stock fell 9.12% since the beginning of the month, reaching $54.7 just over a week before its acquisition by KLA-Tencor was expected to be finalized

Acquisition by Medtronic Complete, Mazor Delists

20.12.18|Lilach Baumer

Medtronic paid $1.3 billion in cash for the Israeli surgical robotics company. Including Medtronic’s existing stake, the deal is valued at $1.7 billion

רמון לגוארטה מנכל פפסיקו דניאל בירנבאום מנכל סודה סטרים מסיבת עיתונאים רכישת סודה סטרים

PepsiCo Completes SodaStream Acquisition

05.12.18|CTech

SodaStream will delist from the Tel Aviv Exchange at Wednesday market close

$10 Million Public Offering Sends Interception Firm’s Stock Plummeting

26.11.18|CTech

Tel Aviv-based Ability Inc. dropped around 46% by Friday market close following its announcement

Electronics 3D Printer Company Nano Dimension Wants to Raise $29 Million on Nasdaq

22.11.18|Lilach Baumer

The Tel Aviv and Nasdaq-listed company submitted a public offering prospectus to the SEC Wednesday

Under New Management, Printer Maker Kornit Reports 32% Increase in Quarterly Revenues

14.11.18|Dror Reich

In August, HP veteran Ronen Samuel replaced Kornit’s former CEO for the past four years, Gabi Seligsohn

Tower Semiconductor's Stock Down 21% Following Underwhelming Third Quarter Results

30.10.18|CTech

Tower reported revenues of $323 million for the quarter ending Sept. 30, down 9% compared with the same period last year, and 3.5% short of prior estimates

Gamida Cell Downprices Shares to Raise $50 Million Nasdaq IPO

28.10.18|Lilach Baumer

The Israel-based biotech company offered its shares at $8, below its previous intention of $13 to $15 per share

Mellanox Considers Sale, Says CNBC Report

26.10.18|Lilach Baumer

Mellanox published its preliminary third-quarter results for 2018, reporting its fifth consecutive quarter of record results

Canada's FSD Pharma to Acquire Israeli Therapix Biosciences for $48 Million in Stock

23.10.18|Lilach Baumer

Clinical-stage Therapix Biosciences develops cannabinoid-based drugs for the treatment of neurological conditions, pain management, and infectious diseases

Global Licensing and Commercialization Deal Catapults Collplant on Nasdaq

22.10.18|Lilach Baumer

The tissue regeneration company announced on Monday a deal with biotech company United Therapeutics and is currently up over 60% in pre-market trading

Novartis-Backed Gamida Downgrades Nasdaq IPO Expectations to $50-$60 Million

18.10.18|Lilach Baumer

The Jerusalem-based biotech company filed for a $69 million initial public offering in September but disclosed no pricing terms

Biotech Company Gamida Cell Files for $69 Million Nasdaq IPO

30.09.18|Dror Reich

The Jerusalem-based company develops cellular and immune therapies. Its lead product is a universal bone marrow transplant solution

Previous Articles More Articles